Management of Chronic Mild Neutropenia with Paraproteinemia

Introduction to Management

The American College of Physicians recommends observation without intervention for a patient with chronic mild neutropenia (ANC 1.2-1.4 × 10⁹/L) and modest paraproteinemia, as this ANC level carries minimal infection risk and does not warrant G-CSF therapy or antimicrobial prophylaxis 1

Patients with severe neutropenia (ANC <0.5 × 10⁹/L) require intervention due to high infection risk, according to the European Hematology Association 2
The International Society for Infectious Diseases recommends against unnecessary antimicrobial prophylaxis in mild neutropenia range, as this promotes antibiotic resistance without proven benefit 1
Antibacterial or antifungal prophylaxis should only be considered when ANC drops below 0.5 × 10⁹/L or in cases of febrile neutropenia, as suggested by the Infectious Diseases Society of America 2

G-CSF therapy is expensive and should be reserved for more severely affected patients with documented Grade 3 or higher neutropenia (ANC <1.0 × 10⁹/L), according to the National Comprehensive Cancer Network 2
Colony-stimulating factors are only recommended when there is documented severe neutropenia or recurrent severe infections, as stated by the American Society of Clinical Oncology 2

Flow cytometry on peripheral blood should be performed to look for monoclonal B-cell population if not already done, as CLL can present with relative lymphocytosis and neutropenia, recommended by the College of American Pathologists 1
If IgG falls below 400 mg/dL, consider IVIG replacement therapy, particularly if recurrent infections develop, as suggested by the Immune Deficiency Foundation 2

Avoid attributing all future infections to the mild neutropenia, as patients with paraproteinemia may have functional hypogammaglobulinemia even with normal total IgG levels, leading to recurrent encapsulated bacterial infections that are not neutropenia-related, warned by the European Society for Immunodeficiencies 2